Completed PHASE1 NCT00001615

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Sponsor: National Eye Institute (NEI)

Conditions Choroidal Neovascularization Macular Degeneration

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Jul 31, 1997 Completion: May 31, 2000

A PHASE1 clinical study on Choroidal Neovascularization and Macular Degeneration, this trial is completed. The trial is conducted by National Eye Institute (NEI) and has accumulated 5 data snapshots since 1997. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States